Evidence mapPaperPMID 32085474Full record

ReviewBiomolecules2020

Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors.

Ewelina Zaorska, Lenka Tomasova, Dominik Koszelewski, Ryszard Ostaszewski, Marcin Ufnal

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Sulfide regulation and catabolism in health and disease.Signal transduction and targeted therapy · 2025
    Review
  9. Hydrogen Sulfide (HInternational journal of molecular sciences · 2025
    Review
  10. Article
  11. Synthesis, HScientific reports · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Signaling Paradigms of HAntioxidants (Basel, Switzerland) · 2024
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ewelina ZaorskaDepartment of Experimental Physiology and Pathophysiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, 02-091 Warsaw, Poland.
Lenka TomasovaInstitute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, 84505 Bratislava, Slovakia.
Dominik KoszelewskiInstitute of Organic Chemistry, Polish Academy of Sciences Kasprzaka 44/52, 01-224 Warsaw, Poland.
Ryszard OstaszewskiInstitute of Organic Chemistry, Polish Academy of Sciences Kasprzaka 44/52, 01-224 Warsaw, Poland.
Marcin UfnalDepartment of Experimental Physiology and Pathophysiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, 02-091 Warsaw, Poland.
Institute of Organic Chemistry · PLMedical University of Warsaw · PLBiomedical Research Center of the Slovak Academy of Sciences · SK

Funding

Narodowym Centrum Nauki UMO-2016/22/E/NZ5/00647.
6 · The paper itself

Abstract

Hydrogen sulfide (H

Indexed as

AnimalsAnti-Inflammatory AgentsHumansHydrogen SulfideSulfurAnti-Inflammatory AgentsHydrogen SulfideSulfuranticancer druganti-inflammatory agentscardiovascularH2S donorsH2S pro-drugshydrogen sulfideneuromodulationsulfur-containing drugs

Identifiers

PMID32085474
PMCPMC7072623
OpenAlexW3006790800

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.